Some Are Calling Monoclonal Antibodies "A Game Changer"

The video discusses the use of monoclonal antibodies in treating COVID-19, highlighting their development by companies like Regeneron and Eli Lilly. It explains how these antibodies target the virus's spike protein to prevent disease progression, though they are not a vaccine substitute. The video also covers efforts to expand access to these treatments across various states, including setting up infusion centers and pharmacy sites. Personal stories illustrate the impact of these treatments, while cost considerations are also addressed.

What challenges are faced in providing monoclonal antibody treatment to patients?

What recent actions have been taken by the FDA regarding monoclonal antibody treatment?